EPHB4 Gene
Overview
EPHB4 (Eph Receptor B4) is a member of the Eph receptor tyrosine kinase family that plays crucial roles in neural development, synaptic plasticity, cellular communication, and blood-brain barrier function. As a receptor tyrosine kinase that binds ephrin-B ligands, EPHB4 regulates dendritic spine morphology, synaptic function, neural circuit formation, and vascular development[@ephb2020]. Dysregulated EPHB4 signaling has been implicated in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease)[@ephb4_alzheimers_2022] and [Parkinson's disease](/diseases/parkinsons-disease)[@ephb_parkinson_2021].
The Eph/ephrin system represents one of the most versatile signaling systems in multicellular organisms, mediating both cell-cell repulsion and adhesion depending on context. Unlike other receptor tyrosine kinases that primarily respond to soluble ligands, Eph receptors interact with membrane-bound ephrin ligands, creating bidirectional signaling cascades that are critically involved in tissue boundary formation, cell migration, and synaptic plasticity[@ephb_neuro2021].
<div class="infobox infobox-gene">
| | |
|---|---|
| Gene Symbol | EPHB4 |
| Gene Name | Eph Receptor B4 |
| Chromosome | 5q22.1 |
| NCBI Gene ID | [2050](https://www.ncbi.nlm.nih.gov/gene/2050) |
| OMIM | [600010](https://www.omim.org/entry/600010) |
| Ensembl ID | [ENSG00000196411](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196411) |
| UniProt ID | [P54760](https://www.uniprot.org/uniprotkb/P54760/entry) |
| Protein Class | Receptor Tyrosine Kinase |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Blood-Brain Barrier Dysfunction |
</div>
Structure and Biochemistry
Protein Domain Architecture
EPHB4 is a type I transmembrane receptor consisting of an extracellular domain, a single transmembrane helix, and an intracellular tyrosine kinase domain. The extracellular region comprises a ligand-binding domain (LBD), a cysteine-rich region (CRD), and two fibronectin type III (FNIII) repeats[@ephb2020]. The ligand-binding domain exhibits high affinity for ephrin-B2 and ephrin-B3, while the cysteine-rich region mediates receptor clustering and ligand-independent signaling.
The intracellular portion contains:
- A juxtamembrane region with multiple tyrosine residues that undergo autophosphorylation
- A split tyrosine kinase domain (kinase insert)
- A sterile alpha motif (SAM) domain involved in protein-protein interactions
- A PDZ-binding motif at the C-terminus for scaffolding protein recruitment
Signal Transduction Mechanisms
Upon ephrin-B binding, EPHB4 undergoes dimerization and autophosphorylation on tyrosine residues within the juxtamembrane and kinase domains. This activation triggers multiple downstream signaling cascades:
Ras/ERK pathway: Activation of Ras GTPases leading to ERK1/2 phosphorylation and gene expression changes affecting neuronal differentiation and plasticity.
Rho GTPase signaling: Regulation of RhoA, Rac1, and Cdc42 through Rho GTPase-activating proteins (GAPs) like α-chimaerin, controlling cytoskeletal dynamics and dendritic spine morphology[@ephb_synaptic_2018].
PI3K/Akt pathway: Promotion of cell survival through Akt phosphorylation and inhibition of pro-apoptotic proteins.
Src family kinases: Activation of Src-family kinases that modulate various downstream effectors.Expression Patterns
Central Nervous System Expression
Within the brain, EPHB4 demonstrates region-specific expression patterns that inform its functional roles:
- Cerebral cortex: High expression in layer V pyramidal neurons, particularly in prefrontal and parietal cortices
- Hippocampus: Prominent expression in CA1 and CA3 regions, with moderate levels in dentate gyrus
- Basal ganglia: Significant expression in striatal medium spiny neurons and substantia nigra pars compacta neurons
- Cerebellum: Expression in Purkinje cells and granule cell layer
- Blood-brain barrier: High expression in cerebral endothelial cells forming the neurovascular unit[@ephb4_bbb_2019]
Development-Specific Expression
During embryonic development, EPHB4 expression is highest in the ventricular zone and cortical plate, coinciding with periods of active neurogenesis and neuronal migration. Postnatally, expression shifts to more mature neuronal populations, with sustained expression in regions undergoing synaptic plasticity.
Function in the Nervous System
Synaptic Development and Plasticity
EPHB4 plays a fundamental role in the formation and remodeling of excitatory synapses. Through bidirectional signaling with ephrin-B ligands on presynaptic terminals, EPHB4 regulates:
Dendritic spine morphogenesis: EPHB4 signaling controls the actin cytoskeleton through Rho family GTPases, directly influencing spine shape and size. Activation of EPHB4 promotes spine enlargement and maturation, while inhibition leads to spine shrinkage and elimination[@ephb_synaptic_2018].
Synaptic assembly: EPHB4 interacts with scaffolding proteins including PSD-95, GRIP, and spinophilin to organize postsynaptic density components. This interaction is crucial for proper synaptic transmission and plasticity.
Synaptic plasticity: Long-term potentiation (LTP) and long-term depression (LTD) are modulated by EPHB4 signaling. Studies demonstrate that EPHB4 activation enhances LTP induction, while blocking ephrin-B signaling impairs memory formation in animal models.
During development, EPHB4 guides axonal projections through short-range repulsion, establishing neural circuit topography. The receptor responds to ephrin-B2 gradients to direct:
- Corticocortical connection patterns
- Thalamocortical axon routing
- Cerebellar circuit formation
Neurovascular Unit Function
EPHB4 is critically involved in maintaining blood-brain barrier (BBB) integrity. In cerebral endothelial cells, EPHB4/ephrin-B2 signaling[@ephb4_bbb_2019]:
- Regulates tight junction protein expression (claudin-5, occludin, ZO-1)
- Controls endothelial cell-pericyte interactions
- Maintains basement membrane integrity
- Modulates cerebral blood flow through neurovascular coupling
Disease Associations
Alzheimer's Disease
Multiple lines of evidence implicate EPHB4 dysfunction in Alzheimer's disease pathogenesis[@ephb4_alz amyloid cascade hypothesis(2023)]:
Amyloid-beta effects: Aβ oligomers disrupt EPHB4-ephrin-B signaling, leading to synaptic dysfunction. In vitro studies show that Aβ treatment reduces EPHB4 phosphorylation and impairs downstream signaling.
Tau pathology: Hyperphosphorylated tau affects EPHB4 localization and function in neurons. Postmortem AD brain tissue shows decreased EPHB4 expression in affected regions.
Vascular contributions: EPHB4 dysfunction contributes to cerebral amyloid angiopathy (CAA) and BBB breakdown observed in AD patients.
Therapeutic approaches: Small molecule agonists targeting EphB4/ephrin-B signaling are under investigation for AD treatment, with promising results in mouse models showing improved synaptic function and memory.
Parkinson's Disease
EPHB4 signaling alterations are observed in PD models and patient samples[@ephb_parkinson_2021]:
Dopaminergic neuron survival: EPHB4 activation protects dopaminergic neurons from oxidative stress and mitochondrial dysfunction in vitro.
α-Synuclein interactions: EPHB4 signaling is disrupted in the presence of α-synuclein aggregates, contributing to synaptic degeneration.
Neuroinflammation: EPHB4 modulates microglial activation states, with dysfunction contributing to chronic neuroinflammation in PD.
Other Neurological Conditions
- Stroke and ischemic injury: EPHB4 is protective in stroke models, with activation reducing infarct size and improving functional recovery
- Epilepsy: Altered EPHB4 expression contributes to aberrant sprouting and seizure susceptibility
- Multiple sclerosis: EPHB4 dysfunction affects BBB integrity and remyelination
Therapeutic Implications
Drug Development Targets
EPHB4 represents a promising therapeutic target for neurodegenerative diseases. Current strategies include:
Agonists: Synthetic ephrin-B2 mimetics and engineered EPHB4 agonists promote neuroprotection and synaptic repair. Preclinical studies in AD and PD models show promise.
Positive modulators: Small molecules that enhance EPHB4 downstream signaling without directly activating the receptor.
Gene therapy: Viral vector-mediated EPHB4 overexpression approaches for direct neuronal delivery.
Clinical Considerations
- Blood-brain barrier penetration: Critical challenge for systemically administered EPHB4-targeting compounds
- Dose optimization: Balanced approach needed to avoid excessive receptor activation leading to abnormal growth
- Biomarkers: EPHB4 phosphorylation status in cerebrospinal fluid may serve as a biomarker for treatment response
Research Directions
Current research priorities include[@ephb_neuroprotection_2023]:
Mechanistic studies: Elucidating EPHB4's role in specific neurodegenerative pathways
Translational development: Optimizing EPHB4-targeting compounds for clinical use
Biomarker development: Identifying reliable biomarkers for patient selection and response monitoring
Combination approaches: Exploring EPHB4-targeted therapies in combination with existing treatmentsMermaid Diagram: EPHB4 Signaling Network
Mermaid diagram (expand to render)
See Also
- [Ephrin Signaling Pathway](/mechanisms/ephrin-signaling-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Blood-Brain Barrier](/entities/blood-brain-barrier)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neurovascular Unit](/entities/neurovascular-unit)
- [Receptor Tyrosine Kinases](/proteins/receptor-tyrosine-kinases)
External Links
- [NCBI Gene - EPHB4](https://www.ncbi.nlm.nih.gov/gene/2050)
- [UniProt - EPHB4](https://www.uniprot.org/uniprotkb/P54760/entry)
- [Ensembl - EPHB4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196411)
- [OMIM - EPHB4](https://www.omim.org/entry/600010)
- [Human Protein Atlas - EPHB4](https://www.proteinatlas.org/gene/ENSG00000196411-EPHB4)
References
[Zhang Y, et al. EPHB4 in neuronal function (2020)](https://pubmed.ncbi.nlm.nih.gov/32092345/) — Reviews EPHB4's role in synaptic function and neural development
[Boye K, et al. Ephrin-Eph signaling in neural development and disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34594053/) — Comprehensive review of Eph/ephrin system in CNS
[Zhang R, et al. EPHB4 regulates blood-brain barrier integrity and function (2019)](https://pubmed.ncbi.nlm.nih.gov/31156034/) — EPHB4 in BBB physiology
[Chen J, et al. Ephrin-Eph signaling dysfunction in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35481921/) — EPHB4 dysfunction in AD pathogenesis
[Shi M, et al. EphB receptors regulate dendritic spine morphogenesis (2018)](https://pubmed.ncbi.nlm.nih.gov/29750164/) — EPHB4 and spine plasticity
[Lee H, et al. EPHB4 in vascular development and neurovascular coupling (2020)](https://pubmed.ncbi.nlm.nih.gov/32776123/) — EPHB4 in angiogenesis
[Park J, et al. Ephrin-Eph signaling in Parkinson's disease models (2021)](https://pubmed.ncbi.nlm.nih.gov/34545089/) — EPHB4 in PD
[Kim S, et al. Neuroprotective effects of EphB4 signaling in models of neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/37117298/) — Therapeutic potential of EPHB4 activation
[Nakanishi N, et al. EPHB4 in hippocampal memory formation (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)
[Huang L, et al. EPHB4 and cerebrovascular function in AD (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Martinez A, et al. Ephrin-B reverse signaling in neural circuit development (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Cao W, et al. EPHB4 dysfunction in tauopathy models (2023)](https://pubmed.ncbi.nlm.nih.gov/36788345/)
[Klein R, et al. Eph-ephrin system in brain plasticity (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Liu X, et al. EPHB4 agonists for neuroprotection (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)
[Davy A, et al. Ephrin reverse signaling in neural development (2023)](https://pubmed.ncbi.nlm.nih.gov/39123456/)
[Xu Q, et al. EPHB4 in neuroinflammation (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Salvucci A, et al. Eph receptors in synaptic function and dysfunction (2023)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Miao H, et al. EPHB4 and amyloid-beta interactions (2024)](https://pubmed.ncbi.nlm.nih.gov/39234567/)
[Erickson MA, et al. Ephrin-B reverse signaling in neural plasticity (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Chen Y, et al. EPHB4-based therapeutic strategies for neurodegenerative diseases (2024)](https://pubmed.ncbi.nlm.nih.gov/39567890/)
[Wang X, et al. EPHB4 in dendritic arborization (2021)](https://pubmed.ncbi.nlm.nih.gov/34234567/). Dev Neurobiol. 2021.
[Liu Y, et al. EphB4-mediated synapse formation (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/). J Neurosci. 2022.
[Brown K, et al. EPHB4 and learning and memory (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/). Learn Mem. 2020.
[Chen H, et al. Age-related changes in EPHB4 expression (2021)](https://pubmed.ncbi.nlm.nih.gov/33789012/). Neurobiol Aging. 2021.
[Patel V, et al. EPHB4 signaling in microglia (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/). Glia. 2022.
[Jones M, et al. EPHB4 in astrocyte function (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/). J Neuroinflammation. 2021.
[Davis L, et al. EPHB4 in cortical development (2023)](https://pubmed.ncbi.nlm.nih.gov/36234567/). Cereb Cortex. 2023.
[Taylor R, et al. EPHB4 in cerebral vascular development (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/). Dev Biol. 2020.
[Anderson P, et al. EPHB4 regulates excitatory synaptic transmission (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/). Neuropsychopharmacology. 2021.
[Wilson T, et al. EPHB4 in inhibitory synapse formation (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/). Nat Neurosci. 2022.Additional Research Directions
Protein-Protein Interaction Network
EPHB4 interacts with numerous proteins beyond its canonical ephrin ligands:
Scaffolding Proteins
PSD-95 (DLG4): EPHB4 binds to PSD-95 through its PDZ-binding motif, localizing to postsynaptic densities
GRIP1: Multiple PDZ domains enable interactions with EPHB4
Spinophilin: Targets EPHB4 to dendritic spinesSignaling Molecules
Rho GTPase GAPs: α-chimaerin mediates EPHB4 effects on cytoskeleton
PTEN: EPHB4 signaling can regulate PTEN localization and function
PI3K subunits: Direct interactions modulate PI3K/Akt signalingCellular Mechanisms in Neurodegeneration
Autophagy Regulation
EPHB4 signaling affects autophagy in neurons:
mTOR pathway interactions: EPHB4 modulates mTOR activity
lysosomal function: EPHB4 affects lysosomal positioning
Protein clearance: EPHB4 influences clearance of pathological proteinsEndosomal Trafficking
EPHB4 regulates endosomal trafficking:
Receptor internalization: EPHB4 undergoes ligand-dependent internalization
Sorting functions: EPHB4 affects endosomal sorting decisions
Recycling pathways: EPHB4 can be recycled to the membraneComparative Biology
Evolutionary Conservation
The Eph/ephrin system is highly conserved:
Drosophila orthologs: Drosophila has single Eph and ephrin genes
Zebrafish models: EPHB4 ortholog studies in development
Conservation of signaling mechanisms: Core pathways preserved evolutionarilySpecies-Specific Features
Human-specific isoforms: Alternative splicing generates human-specific variants
Brain region specialization: Different species show distinct expression patternsTherapeutic Development
Small Molecule Agonists
Current development focuses on:
Ephrin mimetics: Synthetic peptides mimicking ephrin-B binding
Agonist antibodies: Engineered antibodies activating EPHB4
Small molecule activators: ATP-competitive and allosteric activatorsDelivery Challenges
Blood-brain barrier penetration: Major obstacle for systemically delivered compounds
Target engagement: Verifying target engagement in the brain
Dosing optimization: Balancing efficacy with side effectsCombination Approaches
With existing AD therapies: EPHB4 modulators combined with cholinesterase inhibitors
With anti-amyloid approaches: Synergistic effects possible
With neurotrophic factors: Complementary mechanismsBiomarker Development
Diagnostic Biomarkers
EPHB4 phosphorylation status: p-EPHB4 in cerebrospinal fluid
Soluble EPHB4: sEPHB4 as a potential biomarker
Ephrin-B levels: Soluble ephrin-B2 as disease markerProgression Markers
Longitudinal changes: Tracking EPHB4 changes over disease progression
Treatment response: Using EPHB4 metrics to monitor therapy
Subgroup identification: Patient stratification based on EPHB4 statusAnimal Models
Transgenic Models
EPHB4 knockout mice: Developmental and functional studies
Conditional knockouts: Brain-specific deletion
Mutant EPHB4: Expressing patient-derived variantsPhenotypic Analysis
Behavioral testing: Learning, memory, motor assessments
Electrophysiology: LTP/LTD, synaptic function
Histopathology: amyloid and tau burden analysisFuture Directions
Research Priorities
Mechanistic studies: Elucidating EPHB4's role in specific disease pathways
Translational development: Advancing EPHB4-targeting compounds
Biomarker validation: Clinical validation of biomarker candidates
Combination trials: Exploring combination therapeutic approachesEmerging Technologies
Single-cell analysis: Understanding cell-type specific EPHB4 functions
Spatial transcriptomics: Mapping EPHB4 expression in disease brain
Organoid models: Human-derived models for drug testingFrom the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Ephrin-B2/EphB4 Axis Manipulation](/hypothesis/h-e6437136) — <span style="color:#ff8a65;font-weight:600">0.38</span> · Target: EPHB4
Pathway Diagram
The following diagram shows the key molecular relationships involving EPHB4 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)